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high in patients with involvement of bilateral lower limb 
and initial thrombocytopenia.
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Introduction
Necrotizing fasciitis (NF) is an uncommon deep soft tis-
sue infection characterized by a rapidly spreading necrosis 
of superficial fascia and subcutaneous tissue [1]. Although 
typical NF involves primarily a single site, some recent 
studies report the concurrent involvement of multiple sites 
[2–4]. Some reports [2, 5, 6] incidentally indicate that mul-
tifocal necrotizing fasciitis leads to a higher mortality rate 
than does monofocal NF. We found no reports that focused 
primarily on synchronous multifocal necrotizing fasciitis 
(SMNF). Thus, we evaluated the clinical characteristics 
and outcomes of SMNF.
Patients and methods
Patients
We reviewed the records of patients diagnosed with and 
treated for SMNF at our hospital from January 2004 to 
December 2012. SMNF was defined as a multifocal pres-
ence of necrotizing fasciitis (NF) in different extremities at 
the initial visit. It was defined using surgical findings: the 
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presence of grayish necrotic skin, subcutaneous fat and 
fascia, no resistance of normally adherent fascia to digital 
blunt dissection, and a purulent discharge resembling foul-
smelling dishwater. Histopathological tissue specimens 
were obtained to confirm the diagnoses. Exclusion crite-
ria were: (1) monofocal necrotizing fasciitis, (2) central 
necrotizing fasciitis (involvement of trunk or perineum), 
(3) a negative microbiological culture of the infected speci-
men, (4) concomitant chronic infections (e.g., osteomyeli-
tis), and (5) a preexisting chronic wound (e.g., diabetic foot 
ulcer and decubitus ulcer).
Treatment protocol
The treatment protocol included adequate antibiotic therapy 
and prompt radical debridement. All patients underwent 
emergency surgery within 1 h of admission when necrotiz-
ing fasciitis was suspected. Patients with multiple comor-
bidities, or an unstable hemodynamic status (systolic blood 
pressure <90 mmHg or mean arterial pressure <65 mmHg) 
were transferred to the intensive care unit for postoperative 
intensive care. Surgical debridement was done every other 
day if progressive necrotic changes combined with a dete-
riorating clinical presentation. Initial empiric broad-spec-
trum antibiotics were administered and adjusted based on 
blood and tissue culture results. Soft tissue reconstruction 
was done until the infected necrotic tissue was controlled 
and stabilized.
Data analysis
Patient characteristics, presenting signs and symptoms, 
location of infection, underlying comorbidities, laboratory 
findings at the time of admission, bacteriologic results, 
and final outcomes in all patients were reviewed using the 
electronic database at our hospital. In regard to laboratory 
analysis, leukocytosis was defined as a white blood cell 
count greater than 12,000/μl, and thrombocytopenia was 
defined as a platelet count lower than 150,000/μl of blood. 
To assess clinical outcomes after antibiotic therapy and sur-
gical debridement, mortality was defined as death because 
of progressive sepsis or medical complications within 
12 months after surgery. To evaluate the predictive factors 
of mortality in SMNF, the variables were analyzed between 
survivors and non-survivors.
Statistical methods
Univariate analysis was used to determine factors associ-
ated with the survivors and non-survivors. An independent 
Student’s t test was used for numerical data. A χ2 analy-
sis or a Fisher’s exact test was used for categorical data. 
Descriptive data are presented as the mean with standard 
deviation for quantitative variables and as frequency for 
categorical variables. Statistical significance was set at 
p < 0.05. SPSS 12.0 for Windows (SPSS Institute, Chicago, 
IL, USA) was used for all statistical analyses.
Results
Patient characteristics
We reviewed 401 patients diagnosed with NF at our hos-
pital from January 2004 to December 2012. We excluded 
383 patients: 150 with monofocal NF of the extremities, 
88 with NF involving the trunk, 128 with concomitant 
chronic osteomyelitis, surgical wound infection, chronic 
diabetic or decubitus ulcer, and 17 with culture-negative 
NF. Eighteen (5%) patients (14 men, 4 women; mean age 
59 years; age range 38–79 years) (Table 1) were diag-
nosed with SMNF of the extremities. The survivors were 
followed up for a minimum of 1 year (mean 16 months; 
range 12–24 months). Vibrio species [14 (78%) cases] were 
the most common. Others were Aeromonas spp. [2 (11%) 
cases], group A β-hemolytic streptococcus [1 (6%)], and 
coagulase-negative staphylococcus [1 (6%)]. Twelve (67%) 
of the 18 enrolled patients presented in shock on admis-
sion and required aggressive resuscitation. The extrem-
ity distribution of NF included the bilateral lower limbs 
(72%), bilateral upper limbs (17%), and one patient with 
one upper and one lower limb (11%) (Table 2). Fourteen 
patients immediately underwent a fasciotomy and debride-
ment, and four patients (22%) had an initial amputation. 
Twelve patients with SMNF died: ten patients died of the 
uncontrolled original infection, one patient died of compli-
cated pneumonia and a fungal urinary tract infection with 
fungemia, and one patient died of comorbidities [liver cir-
rhosis (Child-Pugh Class C) and upper gastrointestinal 
bleeding] within 4 months after hospital discharge.
Patient characteristics compared
Almost all of the non-survivors developed NF of the bilat-
eral lower limbs, except for one non-survivor with affected 
bilateral upper limbs; all of the survivors had NF of the 
bilateral upper limbs (p = 0.005) (Table 3). Differences in 
age, gender, comorbidities, and duration of symptoms were 
not significant.
Laboratory data compared
Survivors had a higher rate of leukocytosis than did non-
survivors (83 vs. 17%, p = 0.013) (Table 4). The prevalence 
of thrombocytopenia was higher in non-survivors than in 
survivors (92 vs. 17%, p = 0.004). Bacteremia occurred in 
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Table 1  Patient characteristics
PT patient, S/S signs and symptoms, V. Vibrio, CoNS coagulase-negative staphylococci, A. Aeromonas, β-hem. Strep. group A β-hemolytic strep-
tococcus, Klep. Klebsiella, AA alcohol abuse, LC liver cirrhosis, HBV hepatitis B virus, HCV hepatitis C virus, HCC hepatic cell carcinoma, 
DM diabetes mellitus, COPD chronic obstructive pulmonary disease, ESRD end-stage renal disease, AR aortic regurgitation, S shock, F fever, H 
hemorrhagic bullae, P limb pain, NA not available
PT # Age (years) Sex Occupation Microbe Comorbidity S/S at first visit Exposure history
1 38 Male Fisherman V. vulnificus LC, AA S, H, P Seawater
2 38 Male Farmer β-hem. strep. LC, HBV, HCV, AA S, F, P NA
3 58 Male Fisherman V. vulnificus NA F, H, P Seawater
4 70 Male Fisherman V. vulnificus DM S, H, P Seawater
5 76 Male Fisherman CoNS AA, COPD P NA
6 59 Male Plasterer V. vulnificus AA, AR, IE P Fish
7 60 Male Fisherman V. vulnificus LC, AA, ESRD S, H, P Seawater
8 79 Male Farmer V. vulnificus ESRD, gout S, H, P Farmland
9 52 Female NA V. vulnificus LC, HBV, HCV, HCC S, F, P NA
10 57 Male Plasterer V. vulnificus HCV, DM S, F, P Oyster
11 63 Female Barber V. vulnificus LC, HCV S, F, H, P NA
13 51 Male NA V. cholerae LC, HBV, ESRD, AA S, F, H, P Seafood
14 59 Male Farmer A. sobria
Klep. pneumoniae
LC, HCC, AA S, P NA
15 53 Male Plasterer V. vulnificus LC, AA H, P NA
16 79 Male Farmer V. vulnificus DM, AA, AR S, F, H, P NA
17 68 Female Farmer A. hydrophila Steroid abuse S, H, P Bamboo stabbing
18 64 Female Barber V. vulnificus HCV, DM, AR S, F, H, P NA
Table 2  Additional patient 
characteristics
PT patient, RA right arm, LA left arm, RH right hand, LH left hand, RL right leg, LL left leg, RF right foot, 
LF left foot, FD fasciotomy and debridement, AMP amputation, Bil. AMP bilateral amputation
PT # Affected limbs Onset day Antibiotics Initial surgery Outcome
1 RF, LF 3 Ceftriaxone FD Survival
2 RA, LT 2 Ceftriaxone FD Survival
3 RH, LH 1 Imipenem & cilastatin sodium, MSD FD Survival
4 RH, RH 2 Ceftriaxone FD Survival
5 RA, LA 5 Ceftriaxone FD Survival
6 RH, LL 1 Ceftriaxone AMP, FD Survival
7 RL, LL 1.5 Ceftriaxone FD Death
8 RL, LL 1 Imipenem & cilastatin sodium, MSD FD Death
9 RL, LL, LH 1 Ceftriaxone FD Death
10 RL, LL 1 Ceftriaxone Bil. AMP Death
11 RL, LL 1 Ceftriaxone FD Death
12 RL, LL 1 Ceftazidime Bil. AMP Death
13 RL, LL 1 Ceftriaxone FD Death
14 RL, LL 1 Ceftriaxone FD Death
15 RL, LF 1 Ceftriaxone FD Death
16 RL, LL 1 Ceftazidime FD Death
17 RL, LL 1 Ceftriaxone FD Death
18 RH, LH 1 Ceftriaxone Bil. AMP Death
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50% of survivors and in 83% of non-survivors (p = 0.268). 
The levels of serum hemoglobin, C-reactive protein, and 
albumin were not significantly different between the two 
groups.
Bacterial cultures compared
Gram-negative bacteria were predominantly isolated in 
both groups, especially Vibrio vulnificus. There was no sig-
nificant difference in bacterial species between the groups 
(Table 5).
Discussion
This is the first report of a case series of SMNF and 
analysis of its predictive factors for mortality. In the cur-
rent study, SMNF accounted for 5% of NF. The main 
characteristics of our patients with SMNF were male 
sex, lower limb involvement, and marine Gram-negative 
bacterial infection. The incidence of SMNF in noncon-
tiguous sites is not clear in the literature. Park et al. [5], 
in a retrospective case review of 217 patients with NF in 
the coastal area of South Korea, reported that at least 73 
(34%) patients had noncontiguous multifocal involve-
ment with highly frequent isolation of Gram-negative 
marine bacteria. El-Khani et al. [2], in a case report and 
systematic review of 33 cases of multifocal NF, reported 
that most patients were male, that their lower limbs were 
involved, and that there were 18 Gram-positive bacteria, 
6 Gram-negative bacteria, 5 anaerobic bacteria, 1 yeast, 
and 4 polymicrobial isolates in the microbiologic cultures. 
Similar to the findings of Park et al. [5], most of our cases 
Table 3  Comparison of patient 
characteristics
Data are mean ± standard deviation or number (%)
CLD chronic liver diseases: liver cirrhosis, hepatitis B virus, or hepatitis C virus
* p < 0.05
Characteristic Survivors (n = 6) Non-survivors (n = 12) p
Age (years) 57 ± 16 61 ± 10 0.486
Males 6 (100) 8 (67) 0.245
Duration of symptoms (days) 2.3 ± 1.5 1 ± 0.1 0.09
Extremities affected 0.005*
 Bilateral upper 3 (50) 1 (8)
 Bilateral lower 1 (17) 11 (92)
 Both upper and lower 2 (33) 0
Comorbidity
 Diabetes mellitus 1 (17) 2 (17) 1
 ESRD 0 3 (25) 0.515
 CLD 2 (33) 9 (75) 0.141
 Liver cirrhosis 2 (33) 7 (58) 0.31
 Hepatitis B virus or hepatitis C virus 1 (17) 6 (50) 0.152
Table 4  Comparison of laboratory data
 *p < 0.05





5 (83) 2 (17) 0.013*
Thrombocytopenia 1 (17) 11 (92) 0.004*
Hemoglobin (g/dL) 14.0 ± 1.8 13 ± 1.6 0.229
C-reactive protein 
(mg/dL)
198.0 ± 119 61 ± 40 0.061
Albumin (g/dL) 2.4 ± 0.5 2 ± 0.6 0.235
Bacteremia 3 (50) 10 (83) 0.268
Table 5  Comparison of bacterial cultures from tissue specimens
strep. streptococcus, staph. staphylococcus, Klep. Klebsiella





Gram-positive bacteria 2 (33) 0 0.098
Gram-negative bacteria 4 (67) 12 (100)






Vibrio vulnificus 4 (67) 9 (75)
Vibrio cholerae 0 1 (8)
Aeromonas sobria 0 1 (8)
Aeromonas hydrophila 0 1 (8)
Klep. pneumoniae 0 1 (8)
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were classified as type III NF (infection by monomicro-
bial pathogen, usually Gram-negative bacteria). Moreover, 
in 89% of our patients with SMNF, marine bacteria—
Vibrio spp. in 78% and Aeromonas spp. in 11%—were 
most commonly isolated. In contrast, there were 12% type 
I NF (infection by polymicrobial bacteria) and 52% type 
II (infection by a monomicrobial pathogen, usually Gram-
positive bacteria) in El-Khani et al. [2]. The different bac-
teria isolated might be attributable to the different geo-
graphical regions and epidemiology of the cases reported 
[7–9]. Marine bacteria (e.g., Vibrio spp. and Aeromonas 
spp.) are often found in the warm coastal areas of Asia 
(e.g., Taiwan, Hong Kong, South Korea, Singapore, and 
Thailand), the Gulf of Mexico, South America, and Aus-
tralia [10–12]. Also, NF in patients with chronic liver dis-
eases is usually a monomicrobial infection, caused primar-
ily by Gram-negative bacteria [13, 14]. Our hospital is in 
the Tropic of Cancer in southwestern Taiwan, where many 
local inhabitants work in fisheries or consume seafood, 
and where alcoholism, chronic viral hepatitis, and liver 
cirrhosis are highly prevalent. Therefore, a specific epide-
miology, i.e., a high prevalence of chronic liver diseases in 
a coastal area, would make marine Gram-negative bacteria 
the main causative pathogens of SMNF.
The overall mortality rate of our patients with SMNF 
was 67%. Most of the literature focuses only on monofo-
cal NF and reports a cumulative average mortality rate of 
34%. The survival rate for NF patients has risen to as high 
as 85% as the awareness of monofocal NF has increased 
and as more-frequent aggressive treatment and adjuvant 
therapy for the disease have increased. In contrast, multi-
focal NF remains highly fatal. Park et al. [5] reported that 
patients with infections in multiple sites had a mortality 
rate of 62%, significantly higher than the 30% in patients 
with a single-site infection. Similarly, Hua et al. [6], in a 
retrospective single-center cohort study, said that multifo-
cal necrotizing soft tissue infection was an independent risk 
factor for mortality. SMNF might be caused by rapid meta-
static septic embolization or simultaneous multifocal inoc-
ulation and the subsequent development of a necrotizing 
infection. The former implies fulminant septicemia with the 
hematogenous spread of bacteria, and the latter implies that 
more than one site has been concomitantly exposed to path-
ogenic bacteria. Both conditions can lead to overwhelming 
sepsis. Also, a large area of skin, subcutaneous tissue, fas-
cia, and underlying necrotic destruction of muscle in multi-
ple-site necrotic deep soft tissue will cause extensive com-
plications and a high mortality rate. Like extensive NF that 
involves a large surface area of the body [15], an immediate 
fasciotomy and radical removal of necrotic tissue without a 
misdiagnosis is important when treating SMNF. The treat-
ment protocol should consist of prompt antibiotic therapy, 
prolonged intensive care, nutritional support, serial surgical 
debridement, and reconstruction of soft tissue to reduce 
mortality and morbidity rates.
In the present study, non-survivors had a higher preva-
lence of involved bilateral lower limbs and thrombocyto-
penia than did survivors. There is a paucity of reports on 
the risk factors for SMNF mortality. However, the mortal-
ity rate in cases of monofocal NF with upper extremity 
involvement is not significantly different from that in cases 
with lower extremity involvement [16, 17]. El-Khani et al. 
[2] reported a significantly higher mortality rate in bilater-
ally affected lower limbs than in bilaterally affected upper 
limbs (60 vs. 0%), but the clinical mechanism of mortal-
ity related to lower extremity involvement is unclear. In the 
present study, chronic liver diseases were the most com-
mon comorbidities (61%) in SMNF, especially in non-sur-
vivors (75%). Some evidence [18–20] indicates that athero-
sclerosis and cutaneous vasculitis in the lower limbs were 
highly associated with chronic liver diseases (e.g., viral 
hepatitis and alcoholic hepatitis). Also, extrahepatic cuta-
neous vasculitis [21], primarily of the lower limbs, leads 
to cutaneous lesions and to an insufficient barrier against 
bacterial invasions (Fig. 1). Atherosclerosis, vasculitis, and 
devitalized soft tissue are the results of a poor blood supply, 
which causes the clinical deterioration of necrotizing deep 
soft tissue infection [22]. These comorbidities might result 
in a higher prevalence of involved bilateral lower limbs in 
patients who die from NF (Fig. 2). 
Consistent with our findings for multifocal NF, throm-
bocytopenia has also been a predictive factor for mortality 
in monofocal necrotizing deep soft tissue [23, 24]. Physi-
cians should be aware of the grave prognosis for patients 
Fig. 1  Extrahepatic cutaneous dermatitis and vasculitis in patient 
number 13. a Dermatitis with hyperpigmentation-affected bilateral 
lower limbs; b non-blanching purpura were the main characteristics 
of vasculitis
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with SMNF of the bilateral lower limbs and who present 
with thrombocytopenia. Compared with survivors, non-
survivors tended to have lower, but not significantly dif-
ferent, C-reactive protein (CRP) levels. In contrast, Park 
et al. [5] reported that the CRP level was one predictor of 
mortality in NF. Using the CRP level to predict mortality 
is controversial. Many studies [25, 26] have reported that 
CRP levels are not significantly different between survivors 
and non-survivors. Moreover, CRP levels reach peak val-
ues between 48 and 72 h after the onset of bacterial infec-
tion [27], and CRP does not precisely indicate the sever-
ity of bacterial infections at a single time point. In the 
present study, non-survivors had a relatively shorter onset 
of symptoms, which might indicate a lower CRP level on 
admission.
This study has some limitations. This is a case series 
study with a small number of patients, because NF is a rare 
disease and our inclusion criteria were restricted to periph-
eral NF (involvement of extremities). Central NF (involv-
ing head, neck, abdomen, and perineum) was excluded, 
because its etiology and surgical procedures are not similar 
to those of peripheral NF. NF of the head and neck often 
arises from an odontogenic infection with mixed aerobic 
and anaerobic abscesses [28, 29]. NF of the abdomen or 
perineum might be the result of urogenital or colorectal 
infections by enteric microorganisms [30]. A colostomy is 
usually required when treating abdominal or perineal NF 
[31–33]. Moreover, we did not include preexisting chronic 
wounds, of which the etiology might be pyomyositis or 
osteomyelitis. Univariate analysis rather than multivariate 
analysis was used to determine predictive factors for mor-
tality, because there were only a few patients in each group. 
Although this study indicated that the involvement of the 
bilateral lower limbs and thrombocytopenia were highly 
associated with mortality in SMNF, additional studies are 
needed to confirm this.
In conclusion, the incidence of SMNF of the extremities 
was 8% for all subtypes of NF. Male sex, bilateral lower 
limb involvement, and marine Gram-negative bacteria were 
the most frequently found factors in SMNF. The mortality 
of SMNF was as high as 67%, which was more frequently 
associated with initial thrombocytopenia and bilateral 
lower limb involvement. It is essential to detect a multifo-
cal presence of NF in the extremities to justify an immedi-
ate fasciotomy and the radical removal of necrotizing tissue 
after prompt antibiotic therapy and sufficient resuscitation.
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